Zealand Pharma A/S (ZLDPF) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Core Insights - Zealand Pharma is entering what it considers the most exciting year in its 25-year history, focusing on addressing the obesity pandemic and related diseases through its newly launched Metabolic Frontier 2030 strategy [1][2]. Company Focus - The company emphasizes the need for significant new innovations to effectively tackle the healthcare challenges posed by the obesity pandemic [2]. - Zealand Pharma aims to position itself as a leading generational biotech company in metabolic health, with a vision to change the landscape for patients suffering from obesity-related conditions [3].